Clinical Trial

Integrated Diagnosis and Treatment of CKD on Outcomes

Recruiting
View on ClinicalTrials.gov →
Summary
Objective: To establish a study cohort and follow up of patients with CKD in our hospital, and evaluate the status of integrated CKD diagnosis and treatment according to guidelines in the real world, as well as the clinical prognosis of patients with different stratification. Methods: By establishing a cohort of 1000 patients with CKD and conducting long-term follow-up, integrated diagnosis and treatment for CKD was performed, namely: Regular monitoring, control of blood pressure, blood glucose, blood lipid, correction of anemia, minerals - bone metabolic abnormalities, malnutrition, acid and alkali, and electrolyte disorder, diet and exercise, such as the guidance of integrated management, non intrusive, observational studies, prospective cohort were analyzed retrospectively, describe the implementation of the integration of diagnosis and treatment, chronic kidney disease (CKD) Stratified analysis and risk factor analysis were performed for cardiovascular disease and other main endpoint events, so as to objectively reflect the status of integrated treatment of CKD and provide data support for continuous quality improvement of CKD diagnosis and treatment and improvement of clinical prognosis of patients.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2022-02-12.
Status change: Not Yet Recruiting → Recruiting 2022-05-02
Trial Details
NCT Number NCT05242055
Lead Sponsor Capital Medical University
Conditions Chronic Kidney Diseases, Hypertension, Hyperglycemia, Hyperlipidemias, Anemia, Chronic Kidney Disease-Mineral and Bone Disorder, Malnutrition
Enrollment 1,000 participants
Start Date 2022-02-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2022-05-06